Item 7.01. Regulation FD Disclosure.
On November 15, 2021, Cassava Sciences, Inc. (“the Company “) disclosed that
certain government agencies had asked for corporate information and documents.
These were confidential requests and remain confidential.
As of September 22, 2022, the Company has not received any “termination letter”
or the like from any government agency regarding any confidential requests for
corporate information and documents. The Company is unable to establish the
legitimacy of communications circulating on mass media, or elsewhere,
purportedly sent from one such government agency following a request for public
access to private records made under the Freedom of Information Act (FOIA). The
Company expressly disclaims any obligation to respond to any reports or rumors
related to the topic of FOIA.
The information provided in this Current Report is being furnished and shall not
be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act
of 1934, as amended (the “Exchange Act”), or otherwise subject to the
liabilities of that Section. Such information shall not be incorporated by
reference into any filing under the Securities Act of 1933, as amended, or the
Exchange Act, regardless of any incorporation by reference language in such
Item 9.01. Financial Statements and Exhibits.
Exhibit Number Description Cover Page Interactive Data File (embedded within the Inline XBRL 104 document) ?
© Edgar Online, source Glimpses